Encompass Health (NYSE:EHC – Get Free Report) released its quarterly earnings results on Thursday. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12, Zacks reports. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%.
Encompass Health Trading Down 3.7 %
Shares of NYSE EHC traded down $3.79 during trading on Thursday, hitting $98.41. 1,096,305 shares of the company were exchanged, compared to its average volume of 643,975. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health has a 12-month low of $71.99 and a 12-month high of $104.55. The company has a fifty day moving average price of $96.43 and a 200-day moving average price of $95.08. The firm has a market capitalization of $9.91 billion, a PE ratio of 23.77, a P/E/G ratio of 1.18 and a beta of 0.90.
Wall Street Analyst Weigh In
A number of analysts have recently commented on EHC shares. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp increased their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada lifted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $107.11.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Read More
- Five stocks we like better than Encompass Health
- Energy and Oil Stocks Explained
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Plot Fibonacci Price Inflection Levels
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.